Allergies 2016

Holiday Inn Kensington Forum, London UK (July, 06 - 07, 2016)

“So many people interested in this topic and experts with differing expertise sharing their knowledge” - Past Attendee

SMi Group is thrilled to present the 3rd annual Allergies conference, taking place on 6th & 7th July 2016 in Central London, UK. Aimed at an audience of senior scientists and allergy specialists involved in immunology and drug research, Allergies 2016 will provide the perfect platform to discuss pioneering clinical developments and the next generation of allergy therapeutics.

Created with a top panel of industry thought leaders, this year's event will look to capture expert insight by honing in on new pathways with novel vaccines and adjuvants, immunoassays for molecular diagnostic’s, paediatric allergies, personalised treatment, allergen specific immunotherapies, plus much more.

Through strategic direction and regulatory guidance, the programme will look to strengthen knowledge in topics such as biomarker validation, and arm attendees with the key requirements and tools for successful trials and study outcomes.

EXCEPTIONAL SPEAKERS INCLUDE:

·         Dr Anne Marie Salapatek, President & Chief Scientific Officer, Inflamax Research Inc – Conference Chair

·         Dr Jean Cuine, Global Head of Non-Clinical and Pharmaceutical Development, Stallergenes Greer - Conference Chair

·         Dr Carl Dolman, Immunoglobulins and Allergen Study, Director, NIBSC, MHRA

·         Dr Dirk-Jan Opstelten, R&D Director, HAL Allergy

·         Dr Thierry Batard, Senior Dir. Innovation & Technological Platforms, Stallergenes Greer

·         Prof Tim Higenbottam, R&D Director, Allergy Therapeutics Ltd

·         Karen Knipping, Senior Scientist, Danone Nutricia Research

·         Dr Sophie Nutten, Group Leader of the Allergy Group, Nestle Research Centre

·         Prof Kimihiro Okubo, Department of Otorhinolaryngology, Nippon Medical School

KEY REASONS TO ATTEND:

·         Learn about sublingual immunotherapy for cedar pollinosis and mite in Japan

·         Hear the latest updates on regulation and clinical trials for paediatric immunotherapy

·         Obtain an overview of the development of allergen-specific immunotherapy for allergic rhinitis and food allergy

·         Discover the nutritional approaches for primary prevention of allergic disease

For further information or to register, visit the website at http://www.allergies-event.com/gate2biotech